SPY436.98-2.86 -0.65%
DIA343.83+0.02 0.01%
IXIC13,672.99-182.14 -1.31%

BRIEF-Statera Biopharma Submits Phase 3 Clinical Trial Protocol to FDA for Investigational Treatment of Pediatric Crohn’s Disease

reuters.com · 12/29/2021 07:36
BRIEF-Statera Biopharma Submits Phase 3 Clinical Trial Protocol to FDA for Investigational Treatment of Pediatric Crohn’s Disease

- Statera Biopharma Inc STAB:

  • STATERA BIOPHARMA SUBMITS PHASE 3 CLINICAL TRIAL PROTOCOL TO FDA FOR INVESTIGATIONAL TREATMENT OF PEDIATRIC CROHN’S DISEASE

  • STATERA BIOPHARMA INC - TRIAL SITES ARE CURRENTLY BEING SELECTED AND ENROLLMENT IS EXPECTED TO LAUNCH IN EARLY 2022

Source text for Eikon: ID:nGNX60Ck2L

Further company coverage: STAB


((Reuters.Briefs@thomsonreuters.com;;))